"The economics of U.S. healthcare are also at play. To address the root causes of anxiety takes more time, patience, dedication and, yes, money."

Big Pharma companies drive drug development in the first place, so obstructing the benzo revenue without a suitable alternative may lead to better drugs taking longer to develop. I'm assuming the non-benzos (SSRIs like Lexapro) aren't functionally equivalent to the benzos in how they "help" patients, by some measure that is unknown to me.